Miriam Puls
Overview
Explore the profile of Miriam Puls including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
659
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gersch S, Bengel P, Paul N, Ravassa S, von Haehling S, Fischer A, et al.
MedComm (2020)
. 2025 Jan;
6(2):e70069.
PMID: 39830018
No abstract available.
2.
Lange T, Beuthner B, Schulz A, Backhaus S, Evertz R, Rigorth K, et al.
Radiol Cardiothorac Imaging
. 2025 Jan;
7(1):e230380.
PMID: 39785675
Purpose To assess the prognostic implications of cardiac MRI-derived imaging markers in individuals with severe aortic stenosis (AS). Materials and Methods This prospective study (German Clinical Trials Register, DRKS00024479) enrolled...
3.
Elkenani M, Barallobre-Barreiro J, Schnelle M, Mohamed B, Beuthner B, Jacob C, et al.
Front Cardiovasc Med
. 2024 Oct;
11:1398114.
PMID: 39355352
Aims: Patients with severe aortic stenosis (AS), low transvalvular flow (LF) and low gradient (LG) with normal ejection fraction (EF)-are referred to as paradoxical LF-LG AS (PLF-LG). PLF-LG patients develop...
4.
Puls M, Beuthner B, Topci R, Jacob C, Steinhaus K, Paul N, et al.
Clin Res Cardiol
. 2024 Jul;
PMID: 38953944
Background: Substantial controversy exists regarding the clinical benefit of patients with severe paradoxical low-flow, low-gradient aortic stenosis (PLF-LG AS) from TAVI. Therefore, we compared post-TAVI benefit by long-term mortality (all-cause,...
5.
Xu X, Tan X, Cui B, Paul N, Elkenani M, Beuthner B, et al.
Cardiovasc Res
. 2024 Jun;
120(13):1505-1507.
PMID: 38943668
No abstract available.
6.
Alnour F, Beuthner B, Hakroush S, Topci R, Vogelgesang A, Lange T, et al.
EuroIntervention
. 2024 Jun;
20(12):e760-e769.
PMID: 38887885
Background: Cardiac fibrosis plays a major pathophysiological role in any form of chronic heart disease, and high levels are associated with poor outcome. Diffuse and focal cardiac fibrosis are different...
7.
Beuthner B, Elkenani M, Evert K, Mustroph J, Jacob C, Paul N, et al.
ESC Heart Fail
. 2024 Feb;
11(3):1636-1646.
PMID: 38407567
Aims: Studies have reported a strongly varying co-prevalence of aortic stenosis (AS) and cardiac amyloidosis (CA). We sought to histologically determine the co-prevalence of AS and CA in patients undergoing...
8.
Gersch S, Lange T, Beuthner B, Elkenani M, Paul N, Schnelle M, et al.
Clin Res Cardiol
. 2024 Jan;
PMID: 38236417
Background: Patients with severe aortic stenosis (AS) and reduced left ventricular ejection fraction (LVEF) can be distinguished into high- (HG) and low-gradient (LG) subgroups. However, less is known about their...
9.
Puls M
Herz
. 2023 Oct;
48(6):437-447.
PMID: 37831070
In 2020 in Germany, 21,753 patients were hospitalized with the main diagnosis of mitral valve regurgitation (MR), whereby 6050 isolated mitral valve (MV) operations, 4977 combined MV operations and 6011...
10.
Kanwischer L, Xu X, Saifuddin A, Maamari S, Tan X, Alnour F, et al.
Clin Epigenetics
. 2023 Sep;
15(1):149.
PMID: 37697352
Background: Aortic stenosis (AS) is one of the most common cardiac diseases and major cause of morbidity and mortality in the elderly. Transcatheter aortic valve implantation (TAVI) is performed in...